🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🙏These are the lesions where PCI reduces myocardial infarction! #CTguidedPCI PCRonline 🫀 Ziad Ali Javier Escaned Divaka Perera TCTMD Morton J Kern Gregg W. Stone MD William Fearon Natalia Pinilla Prof. Hector M. Garcia-Garcia Mamas A. Mamas MIЯVΛƬ #IC jcspratt Jonathan Hill Rasha Al-Lamee

Fascinating landscape of treatment options to fight coronary plaque. ❤️❤️❤️

If you want to reach for the most precise CV risk model look the one that combines quantitative assessment of plaque, PCAT inflammation and clinical factors.

"You can come back to your cath lab and actually implement that in your clinical practice." — Dr Lukasz Koltowski This isn’t theory—it’s real-world, applicable learning. The CT-Guided PCI Course equips you with tools you can use immediately to improve decision-making,

🚨Deadline extended until 17 June for the call for abstracts or technology & innovation at the #ESCAIsummit2025 The future of cardiovascular health is digital – make sure you play your part 👉bit.ly/45jkXyk #CardiologyInnovation #DigitalHealth #AIinHealthcare

Want to implement PCCT in your PCI pathway? Join us in Aalst 7-8 of June and let’s dive deep into the world of multimodality imaging backed by ultra-high resolution CCTA.

Diagnostyka INOCA istotnie wpływa na leczenie i jakość życia pacjentów, a jednak jej diagnostyka wciąż nie jest refundowana. Wiecej na ten temat: kardiologia.mp.pl/zdaniem-eksper…

This is why Invasive coronary angiogram is a matter of past. Questions is when? #CTguidedPCI #PCCT Optima Education CoreAalst

For invasive coronary angiogram we use intra-artery contrast. For Coronary CT we use intra-venous contrast. The route of administration matters! Another reason to drop ICA. #CCTA #KidneyInjury #ICA Optima Education CoreAalst

👉Managing Dyslipidemia in 2025: The Era of Precision Lipidology ☝️As we move through 2025, dyslipidemia management has clearly evolved beyond the traditional statin + ezetimibe approach. ☝️We now have an expanding armamentarium of targeted therapies addressing